PB 75 of 2013
National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 7)
National Health Act 1953
I, FELICITY MCNEILL, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.
Dated 26 NOVEMBER 2013
FELICITY MCNEILL
First Assistant Secretary
Pharmaceutical Benefits Division
Department of Health
1 Name of Instrument
(1) This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2013 (No. 7).
(2) This Instrument may also be cited as PB 75 of 2013.
2 Commencement
This Instrument commences on 1 December 2013.
3 Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)
Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).
Schedule 1 Amendments
[1] Schedule 1, entry for Allopurinol in the form Tablet 100 mg [Pricing Quantity/Pack Quantity 200]
omit from the column headed “Claimed Price”: 6.33 substitute: 7.51
[2] Schedule 1, entry for Allopurinol in the form Tablet 300 mg
omit from the column headed “Claimed Price”: 4.41 substitute: 5.75
[3] Schedule 1, entry for Amoxycillin in the form Capsule 250 mg (as trihydrate)
omit from the column headed “Claimed Price”: 1.42 substitute: 3.44
[4] Schedule 1, entry for Amoxycillin in the form Capsule 500 mg (as trihydrate)
omit from the column headed “Claimed Price”: 2.27 substitute: 4.28
[5] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 125 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 1.34 substitute: 3.35
[6] Schedule 1, entry for Amoxycillin in the form Powder for oral suspension 250 mg (as trihydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 1.66 substitute: 3.68
[7] Schedule 1, entry for Cefaclor in the form Powder for oral suspension 125 mg (as monohydrate) per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 5.91 substitute: 6.91
[8] Schedule 1, entry for Cefaclor in the form Powder for oral suspension 250 mg (as monohydrate) per 5 mL, 75 mL
omit from the column headed “Claimed Price”: 6.27 substitute: 7.27
[9] Schedule 1, entry for Cefaclor in the form Tablet (sustained release) 375 mg (as monohydrate)
omit from the column headed “Claimed Price”: 7.92 substitute: 8.92
[10] Schedule 1, entry for Cephalexin in the form Capsule 250 mg (anhydrous)
omit from the column headed “Claimed Price”: 3.78 substitute: 4.41
[11] Schedule 1, entry for Cephalexin in the form Capsule 500 mg (anhydrous)
omit from the column headed “Claimed Price”: 5.77 substitute: 6.73
[12] Schedule 1, entry for Cephalexin in the form Granules for oral suspension 125 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 4.26 substitute: 4.95
[13] Schedule 1, entry for Cephalexin in the form Granules for oral suspension 250 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 5.73 substitute: 6.66
[14] Schedule 1, entry for Colchicine
omit from the column headed “Claimed Price”: 4.39 substitute: 6.40
[15] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 5 mg
omit from the column headed “Claimed Price”: 5.97 substitute: 6.69
[16] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 10 mg
omit from the column headed “Claimed Price”: 7.85 substitute: 8.56
[17] Schedule 1, entry for Enalapril in the form Tablet containing enalapril maleate 20 mg
omit from the column headed “Claimed Price”: 9.18 substitute: 9.89
[18] Schedule 1, entry for Felodipine in the form Tablet 2.5 mg (extended release)
omit from the column headed “Claimed Price”: 7.48 substitute: 7.31
[19] Schedule 1, entry for Felodipine in the form Tablet 5 mg (extended release)
omit from the column headed “Claimed Price”: 9.32 substitute: 9.14
[20] Schedule 1, entry for Felodipine in the form Tablet 10 mg (extended release)
omit from the column headed “Claimed Price”: 14.21 substitute: 14.03
[21] Schedule 1, omit entry for Lansoprazole
[22] Schedule 1, entry for Lisinopril in the form Tablet 5 mg
omit from the column headed “Claimed Price”: 5.88 substitute: 6.52
[23] Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Prinivil 10]
omit from the column headed “Claimed Price”: 7.63 substitute: 8.27
[24] Schedule 1, entry for Lisinopril in the form Tablet 10 mg [Zestril]
omit from the column headed “Claimed Price”: 7.62 substitute: 8.26
[25] Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Prinivil 20]
omit from the column headed “Claimed Price”: 8.98 substitute: 9.63
[26] Schedule 1, entry for Lisinopril in the form Tablet 20 mg [Zestril]
omit from the column headed “Claimed Price”: 8.98 substitute: 9.63
[27] Schedule 1, entry for Mometasone in the form Cream containing mometasone furoate 1 mg per g, 15 g
omit from the column headed “Claimed Price”: 7.43 substitute: 7.88
[28] Schedule 1, entry for Mometasone in the form Lotion containing mometasone furoate 1 mg per g, 30 mL
omit from the column headed “Claimed Price”: 10.37 substitute: 10.81
[29] Schedule 1, entry for Mometasone in the form Ointment containing mometasone furoate 1 mg per g, 15 g
omit from the column headed “Claimed Price”: 7.43 substitute: 7.88
[30] Schedule 1, entry for Nitrazepam
(a) omit from the column headed “Determined Price”: 1.13 substitute: 1.50
(b) omit from the column headed “Claimed Price”: 2.31 substitute: 2.68
[31] Schedule 1, entry for Nystatin
omit from the column headed “Claimed Price”: 5.44 substitute: 6.25
[32] Schedule 1, entry for Omeprazole
omit from the column headed “Claimed Price”: 11.00 substitute: 11.66
[33] Schedule 1, entry for Paroxetine
omit from the column headed “Claimed Price”: 6.78 substitute: 8.09
[34] Schedule 1, entry for Prednisolone in the form Oral solution 5 mg (as sodium phosphate) per mL, 30 mL
omit from the column headed “Claimed Price”: 8.60 substitute: 8.88
[35] Schedule 1, entry for Simvastatin in the form Tablet 5 mg
omit from the column headed “Claimed Price”: 4.03 substitute: 5.23
[36] Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Lipex 10]
omit from the column headed “Claimed Price”: 5.00 substitute: 6.20
[37] Schedule 1, entry for Simvastatin in the form Tablet 10 mg [Zocor]
omit from the column headed “Claimed Price”: 5.00 substitute: 6.20
[38] Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Lipex 20]
omit from the column headed “Claimed Price”: 6.54 substitute: 7.74
[39] Schedule 1, entry for Simvastatin in the form Tablet 20 mg [Zocor]
omit from the column headed “Claimed Price”: 6.54 substitute: 7.74
[40] Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Lipex 40]
omit from the column headed “Claimed Price”: 8.77 substitute: 9.96
[41] Schedule 1, entry for Simvastatin in the form Tablet 40 mg [Zocor]
omit from the column headed “Claimed Price”: 8.77 substitute: 9.96
[42] Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Lipex 80]
omit from the column headed “Claimed Price”: 11.95 substitute: 13.15
[43] Schedule 1, entry for Simvastatin in the form Tablet 80 mg [Zocor]
omit from the column headed “Claimed Price”: 11.95 substitute: 13.15
[44] Schedule 1, entry for Sucralfate
omit from the column headed “Claimed Price”: 17.02 substitute: 17.42
[45] Schedule 1, after entry for Telmisartan in the form Tablet 80 mg
insert:
Telmisartan with Hydrochlorothiazide
Tablet 40 mg-12.5 mg
Oral
Micardis Plus 40/12.5 mg
28
6.68
8.71
Tablet 80 mg-12.5 mg
Oral
Micardis Plus 80/12.5 mg
28
16.69
18.71
Tablet 80 mg-25 mg
Oral
Micardis Plus 80/25 mg
28
18.10
20.13
[46] Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Paediatric oral suspension 40 mg-200 mg per 5 mL, 100 mL
omit from the column headed “Claimed Price”: 3.48 substitute: 5.47
[47] Schedule 1, entry for Trimethoprim with Sulfamethoxazole in the form Tablet 160 mg-800 mg
omit from the column headed “Claimed Price”: 3.46 substitute: 5.43
